MedTrace Logo

Adrenal Function in GHD Children

NCT03203356 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2017-06-29

No results posted yet for this study

Summary

To evaluate in children affected by idiopathic GHD the adrenal function both at baseline and after 6 and 12 months of GH treatment.

Conditions

  • Growth Hormone Treatment
  • Adrenal; Functional Disturbance

Interventions

DRUG

growth hormone

Children with a diagnosis of GHD will practice GH replacement therapy in line with normal clinical practice and international guidelines. Controls will be evaluated just at baseline.

Sponsors & Collaborators

  • University of Palermo

    lead OTHER

Eligibility

Min Age
5 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-05-30
Primary Completion
2017-05-01
Completion
2017-05-30

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03203356 on ClinicalTrials.gov